Metoprolol for Migraine Prevention: Efficacy and Mechanism
Metoprolol (a β₁‑selective beta‑blocker) is a first‑line preventive medication for episodic migraine, supported by Level A evidence (AAN/AHS guidelines).
Mechanism
- Blocks β‑adrenergic receptors → reduces catecholamine‑induced cerebral vasodilation and neuronal excitability.
- May stabilize cortical spreading depression (CSD) and modulate trigeminovascular system.
- Central effects: crosses blood‑brain barrier; may influence serotonin and noradrenaline pathways.
Dosing and Efficacy
- Typical dose: 50–200 mg/day (divided or extended‑release).
- ~50% of patients achieve ≥50% reduction in migraine frequency.
- Onset: 4–8 weeks for full effect.
Considerations
- Contraindicated in asthma, severe bradycardia, heart block, decompensated heart failure.
- Side effects: fatigue, dizziness, depression, sexual dysfunction, exercise intolerance.
- Not for acute attacks; use triptans/NSAIDs for breakthrough.
Discuss with a neurologist or headache specialist to determine if metoprolol fits your profile.
Migraine - Related Articles
- Cluster Headaches: Patterns, Features, and Management
- Migraine Relief: Effective Treatments & Symptom Management
- Imitrex (Sumatriptan) Side Effects: What to Expect
- Eye Migraine Relief: Symptoms, Causes & Treatment
- Migraine Relief: Effective Treatments & Prevention Strategies
- Migraine Relief: Medications & Prevention Strategies
- Botox for Chronic Migraine: Mechanism, Efficacy, and Practical Considerations
